Your browser doesn't support javascript.
loading
Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study.
Gupta, Vikas; Wolleschak, Denise; Hasselbalch, Hans; Vannucchi, Alessandro Maria; Koschmieder, Steffen; Cervantes, Francisco; Li, Yang; Dong, Tuochuan; Wroclawska, Monika; Bharathy, Savita; Harrison, Claire.
Afiliação
  • Gupta V; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Wolleschak D; Department of Hematology and Oncology, University Medical Center Magdeburg, Magdeburg, Germany.
  • Hasselbalch H; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Vannucchi AM; Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.
  • Koschmieder S; Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
  • Cervantes F; Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Li Y; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Dong T; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Wroclawska M; Novartis AG, Basel, Switzerland; and.
  • Bharathy S; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Harrison C; Guy's and St Thomas' National Health Service Foundation Trust, Guy's Hospital, London, United Kingdom.
Blood Adv ; 4(13): 3063-3071, 2020 07 14.
Article em En | MEDLINE | ID: mdl-32634234
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Idioma: En Ano de publicação: 2020 Tipo de documento: Article